×
News Home

BioMarin Pharmaceutical Inc. (BMRN) Stock Declines -1.46% This Week; Should You Buy?

Thursday, August 05, 2021 01:12 PM | InvestorsObserver Analysts
BioMarin Pharmaceutical Inc. (BMRN) Stock Declines -1.46% This Week; Should You Buy?

BioMarin Pharmaceutical Inc. (BMRN) stock is down -35.44% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives BMRN stock a score of 27 out of a possible 100. That rank is influenced by a short-term technical score of 12. BMRN's rank also includes a fundamental score of 26. In addition to the average rating from Wall Street analysts, BMRN stock has a mean target price of $106.20. This means analysts expect the stock to gain 37.28% over the next 12 months. The long-term technical score for BMRN is 43.

Overall Score - 27
BMRN has an Overall Score of 27. Find out what this means to you and get the rest of the rankings on BMRN!

What's Happening with BMRN Stock Today

BioMarin Pharmaceutical Inc. (BMRN) stock is up 1.2% while the S&P 500 has risen 0.33% as of 1:06 PM on Thursday, Aug 5. BMRN has risen $0.92 from the previous closing price of $76.44 on volume of 418,594 shares. Over the past year the S&P 500 has gained 32.74% while BMRN is down -35.44%. BMRN earned $4.26 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 18.18. Click Here to get the full Stock Report for BioMarin Pharmaceutical Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App